Nang Kuang Pharmaceutical Co., Ltd. (1752.TW)
TWD 43.35
(-0.12%)
TWD 43.35
(-0.12%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 495.65 Million TWD | 33.57% |
| 2022 | 371.09 Million TWD | 9.78% |
| 2021 | 338.01 Million TWD | -9.02% |
| 2020 | 371.53 Million TWD | -0.75% |
| 2019 | 374.33 Million TWD | 0.66% |
| 2018 | 371.87 Million TWD | 4.66% |
| 2017 | 355.32 Million TWD | 2.72% |
| 2016 | 345.92 Million TWD | 2.25% |
| 2015 | 338.32 Million TWD | 6.45% |
| 2014 | 317.8 Million TWD | 7.02% |
| 2013 | 296.97 Million TWD | 21.95% |
| 2012 | 243.52 Million TWD | 4.82% |
| 2011 | 232.32 Million TWD | 4.66% |
| 2010 | 221.97 Million TWD | -0.21% |
| 2009 | 222.45 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 107.96 Million TWD | -41.41% |
| 2024 Q2 | 96.08 Million TWD | -11.0% |
| 2023 Q4 | 184.27 Million TWD | 73.0% |
| 2023 Q3 | 106.51 Million TWD | 3.32% |
| 2023 FY | 495.65 Million TWD | 33.57% |
| 2023 Q1 | 104.05 Million TWD | 4.67% |
| 2023 Q2 | 103.09 Million TWD | -0.92% |
| 2022 Q1 | 87.3 Million TWD | 3.33% |
| 2022 FY | 371.09 Million TWD | 9.78% |
| 2022 Q4 | 99.41 Million TWD | 3.54% |
| 2022 Q3 | 96.01 Million TWD | 8.67% |
| 2022 Q2 | 88.35 Million TWD | 1.21% |
| 2021 Q4 | 84.48 Million TWD | -1.76% |
| 2021 Q1 | 83.69 Million TWD | -11.28% |
| 2021 Q2 | 83.84 Million TWD | 0.18% |
| 2021 FY | 338.01 Million TWD | -9.02% |
| 2021 Q3 | 85.99 Million TWD | 2.57% |
| 2020 Q3 | 91.02 Million TWD | -4.84% |
| 2020 Q2 | 95.65 Million TWD | 5.66% |
| 2020 Q4 | 94.33 Million TWD | 3.64% |
| 2020 Q1 | 90.52 Million TWD | -21.53% |
| 2020 FY | 371.53 Million TWD | -0.75% |
| 2019 Q4 | 115.35 Million TWD | 29.59% |
| 2019 Q2 | 87.81 Million TWD | 6.91% |
| 2019 Q1 | 82.14 Million TWD | -7.97% |
| 2019 FY | 374.33 Million TWD | 0.66% |
| 2019 Q3 | 89.01 Million TWD | 1.37% |
| 2018 FY | 371.87 Million TWD | 4.66% |
| 2018 Q4 | 89.25 Million TWD | -4.32% |
| 2018 Q3 | 93.28 Million TWD | -6.72% |
| 2018 Q2 | 100 Million TWD | 11.96% |
| 2018 Q1 | 89.32 Million TWD | -12.55% |
| 2017 FY | 355.32 Million TWD | 2.72% |
| 2017 Q4 | 102.14 Million TWD | 13.49% |
| 2017 Q3 | 90 Million TWD | 8.17% |
| 2017 Q1 | 79.96 Million TWD | -10.03% |
| 2017 Q2 | 83.2 Million TWD | 4.05% |
| 2016 FY | 345.92 Million TWD | 2.25% |
| 2016 Q4 | 88.88 Million TWD | 0.61% |
| 2016 Q3 | 88.35 Million TWD | 1.63% |
| 2016 Q2 | 86.93 Million TWD | 6.33% |
| 2016 Q1 | 81.75 Million TWD | -14.91% |
| 2015 Q2 | 80.47 Million TWD | 1.64% |
| 2015 Q3 | 82.58 Million TWD | 2.62% |
| 2015 Q4 | 96.07 Million TWD | 16.34% |
| 2015 FY | 338.32 Million TWD | 6.45% |
| 2015 Q1 | 79.18 Million TWD | 1.78% |
| 2014 Q3 | 78.93 Million TWD | 2.55% |
| 2014 Q1 | 84.1 Million TWD | -2.16% |
| 2014 FY | 317.8 Million TWD | 7.02% |
| 2014 Q4 | 77.79 Million TWD | -1.44% |
| 2014 Q2 | 76.96 Million TWD | -8.49% |
| 2013 Q2 | 78.74 Million TWD | 20.1% |
| 2013 Q4 | 85.96 Million TWD | 28.88% |
| 2013 FY | 296.97 Million TWD | 21.95% |
| 2013 Q1 | 65.56 Million TWD | -1.27% |
| 2013 Q3 | 66.7 Million TWD | -15.29% |
| 2012 Q1 | 58.25 Million TWD | -5.23% |
| 2012 Q2 | 56.4 Million TWD | -3.16% |
| 2012 FY | 243.52 Million TWD | 4.82% |
| 2012 Q3 | 62.04 Million TWD | 9.99% |
| 2012 Q4 | 66.4 Million TWD | 7.03% |
| 2011 Q2 | 54.26 Million TWD | -13.11% |
| 2011 Q1 | 62.44 Million TWD | 12.18% |
| 2011 Q4 | 61.46 Million TWD | 13.52% |
| 2011 Q3 | 54.14 Million TWD | -0.21% |
| 2011 FY | 232.32 Million TWD | 4.66% |
| 2010 Q3 | 51.24 Million TWD | -10.95% |
| 2010 Q2 | 57.54 Million TWD | 0.05% |
| 2010 Q1 | 57.51 Million TWD | 0.0% |
| 2010 Q4 | 55.66 Million TWD | 8.63% |
| 2010 FY | 221.97 Million TWD | -0.21% |
| 2009 FY | 222.45 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Maxigen Biotech Inc. | 274.24 Million TWD | -80.734% |
| SciVision Biotech Inc. | 312.85 Million TWD | -58.428% |
| Bionime Corporation | 673.63 Million TWD | 26.421% |
| Pegavision Corporation | 1.68 Billion TWD | 70.622% |
| Visco Vision Inc. | 522.44 Million TWD | 5.129% |